Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
In vitro potency of xeruborbactam in combination with multiple β-lactam antibiotics in comparison with other β-lactam/β-lactamase inhibitor (BLI) combinations against carbapenem-resistant and extended-spectrum β-lactamase-producing Enterobacterales.
Journal: Antimicrobial agents and chemotherapy
Published: October 06, 2023
Intrinsic Antibacterial Activity of Xeruborbactam In Vitro: Assessing Spectrum and Mode of Action.
Journal: Antimicrobial agents and chemotherapy
Published: September 14, 2022
Crosstalk between CYP2E1 and PPARα substrates and agonists modulate adipose browning and obesity.
Journal: Acta pharmaceutica Sinica. B
Published: November 18, 2021
Metabolic map of the antiviral drug podophyllotoxin provides insights into hepatotoxicity.
Journal: Xenobiotica; the fate of foreign compounds in biological systems
Published: July 28, 2021
QPX7728, An Ultra-Broad-Spectrum B-Lactamase Inhibitor for Intravenous and Oral Therapy: Overview of Biochemical and Microbiological Characteristics.
Journal: Frontiers in microbiology
Published: April 19, 2021
In Vitro Activity of the Ultrabroad-Spectrum Beta-Lactamase Inhibitor QPX7728 in Combination with Multiple Beta-Lactam Antibiotics against Pseudomonas aeruginosa.
Journal: Antimicrobial agents and chemotherapy
Published: February 03, 2021
In Vitro Activity of the Ultra-Broad-Spectrum Beta-Lactamase Inhibitor QPX7728 in Combination with Meropenem against Clinical Isolates of Carbapenem-Resistant Acinetobacter baumannii.
Journal: Antimicrobial agents and chemotherapy
Published: July 02, 2020
In Vitro Activity of the Ultrabroad-Spectrum-Beta-Lactamase Inhibitor QPX7728 against Carbapenem-Resistant Enterobacterales with Varying Intrinsic and Acquired Resistance Mechanisms.
Journal: Antimicrobial agents and chemotherapy
Published: April 17, 2020
Impact of Intrinsic Resistance Mechanisms on Potency of QPX7728, a New Ultrabroad-Spectrum Beta-Lactamase Inhibitor of Serine and Metallo-Beta-Lactamases in Enterobacteriaceae, Pseudomonas aeruginosa, and Acinetobacter baumannii.
Journal: Antimicrobial agents and chemotherapy
Published: March 22, 2020
Discovery of Cyclic Boronic Acid QPX7728, an Ultrabroad-Spectrum Inhibitor of Serine and Metallo-β-lactamases.
Journal: Journal of medicinal chemistry
Published: March 10, 2020
Spectrum of Beta-Lactamase Inhibition by the Cyclic Boronate QPX7728, an Ultrabroad-Spectrum Beta-Lactamase Inhibitor of Serine and Metallo-Beta-Lactamases: Enhancement of Activity of Multiple Antibiotics against Isogenic Strains Expressing Single Beta-Lactamases.
Journal: Antimicrobial agents and chemotherapy
Published: January 31, 2020
Rutaecarpine inhibits KEAP1-NRF2 interaction to activate NRF2 and ameliorate dextran sulfate sodium-induced colitis.
Journal: Free radical biology & medicine
Published: November 12, 2019
Last Updated: 09/26/2026